141 related articles for article (PubMed ID: 21787315)
21. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
[TBL] [Abstract][Full Text] [Related]
23. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
[TBL] [Abstract][Full Text] [Related]
24. Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction.
Yan Y; Liu Y; Sorci M; Belfort G; Lustbader JW; Yan SS; Wang C
Biochemistry; 2007 Feb; 46(7):1724-31. PubMed ID: 17253767
[TBL] [Abstract][Full Text] [Related]
25. In silico-designed novel non-peptidic ABAD L
Viswanath ANI; Kim T; Jung SY; Lim SM; Pae AN
Chem Biol Drug Des; 2017 Dec; 90(6):1041-1055. PubMed ID: 28660722
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).
Yan SD; Stern DM
Int J Exp Pathol; 2005 Jun; 86(3):161-71. PubMed ID: 15910550
[TBL] [Abstract][Full Text] [Related]
27. Deposition of Alzheimer's vascular amyloid-beta is associated with decreased expression of brain L-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB).
Frackowiak J; Mazur-Kolecka B; Kaczmarski W; Dickson D
Brain Res; 2001 Jul; 907(1-2):44-53. PubMed ID: 11430884
[TBL] [Abstract][Full Text] [Related]
28. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
[TBL] [Abstract][Full Text] [Related]
30. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model.
Yao J; Taylor M; Davey F; Ren Y; Aiton J; Coote P; Fang F; Chen JX; Yan SD; Gunn-Moore FJ
Mol Cell Neurosci; 2007 Jun; 35(2):377-82. PubMed ID: 17490890
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial import and degradation of amyloid-β peptide.
Pinho CM; Teixeira PF; Glaser E
Biochim Biophys Acta; 2014 Jul; 1837(7):1069-74. PubMed ID: 24561226
[TBL] [Abstract][Full Text] [Related]
32. Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.
Yao J; Irwin R; Chen S; Hamilton R; Cadenas E; Brinton RD
Neurobiol Aging; 2012 Aug; 33(8):1507-21. PubMed ID: 21514693
[TBL] [Abstract][Full Text] [Related]
33. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
He XY; Isaacs C; Yang SY
J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
[TBL] [Abstract][Full Text] [Related]
34. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
[TBL] [Abstract][Full Text] [Related]
35. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
He XY; Dobkin C; Brown WT; Yang SY
J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
[TBL] [Abstract][Full Text] [Related]
36. [Cloning and expression of fusion gene of amyloid beta binding alcohol dehydrogenase decoy peptide aptamer (TRX1-ABAD-DP-TRX2)].
Wang X; Wu J; Yang Y; Wang MY; Che LH; Yang Y
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(1):50-4. PubMed ID: 22490659
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-β and the failure to form mitochondrial cristae: a biomimetic study involving artificial membranes.
Khalifat N; Puff N; Dliaa M; Angelova MI
J Alzheimers Dis; 2012; 28(1):33-48. PubMed ID: 21987591
[TBL] [Abstract][Full Text] [Related]
38. [Effects of acupuncture and moxibustion on energy metabolism-related protein of hippocampal neuron mitochondria in Alzheimer's disease rats].
Luo L; Sun GJ; Du YJ
Zhongguo Zhen Jiu; 2013 Oct; 33(10):913-8. PubMed ID: 24377225
[TBL] [Abstract][Full Text] [Related]
39. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
Yang SY; He XY; Miller D
Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
[TBL] [Abstract][Full Text] [Related]
40. Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease.
Oppermann UC; Salim S; Tjernberg LO; Terenius L; Jörnvall H
FEBS Lett; 1999 May; 451(3):238-42. PubMed ID: 10371197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
